https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55823 Wed 26 Jun 2024 16:19:21 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52270 Wed 20 Mar 2024 14:41:51 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55743 Wed 19 Jun 2024 15:30:21 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29252 p = .019) and Week-4 (83 vs 75 nmol/L; p = .030) in the Active-group, but not at Week-26. At week-4, there were no differences in 2.4 m gait-velocity (0.42 m/s vs 0.39 m/s, p = .490), fractures (2.7 % vs 2.8 %, p = .964) but Active participants reported less falls (6.3 % vs 21.1 %, χ² = 4.327; p = 0.024), with no significant reduction in deaths at week-4 (1 vs 3, p = 0.295), higher percentage reporting ‘no pain or discomfort’ (96.4 % vs 88.8 %, p = 0.037), and trended for higher EuroQoL-scores (p = 0.092) at week-26. One case of hypercalcemia at week-2 normalised by week-4. Conclusion: Among older people after hip fracture surgery, the REVITAHIP strategy is a safe and low cost method of improving vitamin-D levels, reducing falls and pain levels.]]> Wed 11 Apr 2018 11:18:26 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55511 Tue 04 Jun 2024 20:55:31 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42081 Thu 18 Aug 2022 11:12:28 AEST ]]>